No Omicron fatalities from J&J vaccine study yet in SA - SAMRC

No Omicron fatalities from J&J vaccine study yet in SA - SAMRC

The South African Medical Research Council says there has been no Covid-19 Omicron related fatalities from those who took the Johnson & Johnson vaccine study. 

A nurse prepares a dose of the AstraZeneca vaccine against COVID-19 during the first day of the application of the third dose to people over 60 years-old at the Centro de Estudios Superiores Navales (CENCIS) in Mexico City, on December 7, 2021.

"That's good news it shows that the vaccine is effective against severe disease and death and that's reassuring,” said Glenda Gray, SAMRC CEO.

She made the remarks at a Discovery Health virtual press briefing on Tuesday.

 READ: UK to lift Covid travel ban on arrivals from Africa

Officials gave insight on the results of a study carried out by the Discovery Health team and researchers from the South Africa Medical Research Council.  

The study was carried out on the Omicron infection from the 15th of November to 7th of December 2021. 

She says about 218 000 have received the J&J booster shot.

 We finished the Sisonke boost on Friday, so if you haven't been vaccinated, go out and get vaccinated. 

"If you do register and you have a DVD voucher you can still redeem your J&J vaccine afterwards and we hope soon that other essential workers like teachers and policemen who got the single dose will be able to get the booster soon as SAPHRA is busy evaluating the data from the study.”

newswatch new banner 2

Show's Stories